NCT02357082

Brief Summary

Registry intends to prospectively collect data regarding the safety of magnetic resonance imaging (MRI) studies in patients with cardiac pacemakers on implantable cardioverter defibrillators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2015

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 6, 2015

Completed
1.8 years until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2022

Completed
Last Updated

June 10, 2022

Status Verified

June 1, 2022

Enrollment Period

5.4 years

First QC Date

January 20, 2015

Last Update Submit

June 8, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • Cardiac Implantable Electronic Device Lead Impedance at Different Timepoints

    Baseline, Visit 1, 3 months, 6 months

  • Cardiac Implantable Electronic Device Lead Threshold at Different Timepoints

    Baseline, Visit 1, 3 months, 6 months

  • P/R Wave Amplitude at Different Timepoints

    Baseline, Visit 1, 3 months, 6 months

Study Arms (1)

MRI Scan

Patients with a previously implanted Cardiac Implantable Electronic Device who are undergoing an MRI Scan for clinically indicated, diagnostic purposes.

Radiation: MRI Scan

Interventions

MRI ScanRADIATION

MRI scan with Specific Absorption Rate (SAR) limit of 1.5 watts per kilogram of body weight

Also known as: Magnetic Resonance Imaging
MRI Scan

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at Mayo Clinic who have a previously implanted CIED and are scheduled for a clinically-indicated MRI will be included in the registry.

You may qualify if:

  • Strong clinical indication for MRI; in the clinical setting where MRI is the diagnostic modality of choice for a specific disease state without acceptable alternative imaging technology
  • Male or Female
  • years of age or older
  • Able to provide informed consent
  • Presence of CIED

You may not qualify if:

  • Presence of metallic objects that represent a contraindication to MR imaging, including: MRI-unsafe intra-orbital or intra-ocular retained metal fragments, and MRI-unsafe intracranial vascular clips and coils, other MRI-unsafe devices
  • Morbid obesity (abdominal diameter greater than 60 centimeters) which results in contact wiht the magnet bore.
  • Pregnant at time of scanning Pacemaker or Implanted Cardiac Device that is labeled as MRI-Conditional (approved by the Food and Drug Administration for exposure to MRI)
  • Pacemaker dependent and either: 1) device implanted before 2005, or 2) advisory pulse generator that may lower outputs in the setting of radiofrequency currents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Interventions

Magnetic Resonance Spectroscopy

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Paul A Friedman, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 20, 2015

First Posted

February 6, 2015

Study Start

December 1, 2016

Primary Completion

April 20, 2022

Study Completion

April 20, 2022

Last Updated

June 10, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations